October 20, 2025 – Amidst the vigorous development momentum of China's innovative drug sector, the highly anticipated "2025 Top 100 Innovative Pharmaceutical Companies in China" list was officially released. Biokin Pharmaceutical secured a position in the list's first tier.

This list was compiled by Healthcare Ｅxecutive, a professional media platform in the Chinese pharmaceutical industry affiliated with the China Pharmaceutical Enterprise Management Association. The selection was based on competitive intelligence and clinical trial data from Cortellis, as well as patent data from Derwent Innovation. It was ultimately formed through data screening and integrated analysis, relying on a "Three-Dimensions and Four-Indicators" evaluation system.

Healthcare Ｅxecutive is a professional media platform within the Chinese pharmaceutical industry, affiliated with the China Pharmaceutical Enterprise Management Association, and focuses on pharmaceutical industry news reporting and data analysis. Cortellis is a global leader in providing transformative intelligence.